Dorsey Wright & Associates’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Dorsey Wright & Associates’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-4,564	Closed	-$343K	–	136
2014 Q4	$343K	Sell	4,564 -1,686	-27%	-$92.1K	0.16%	89
2014 Q3	$326K	Sell	6,250 -7,616	-55%	-$387K	0.05%	105
2014 Q2	$683K	Buy	13,866 +6,938	+100%	+$335K	0.08%	80
2014 Q1	$324K	Buy	+6,928	New	+$327K	0.05%	100

Other funds holding XPH

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.99B AUM 30.41% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Hoxton Financial Shepherdstown, West Virginia $194M AUM 6.21% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Dorsey Wright & Associates's XPH Position: Q1 2015 in Review

Dorsey Wright & Associates sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2015, closing a stake of 4,564 shares — an estimated $343K sold.

Dorsey Wright & Associates first reported a position in XPH in Q1 2014 and held it in 4 quarters. The position peaked at $683K in Q2 2014. 79 funds tracked by Wall St. Rank hold XPH as of Q1 2015.

Dorsey Wright & Associates reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2015 after selling out during the quarter.
Dorsey Wright & Associates sold 4,564 State Street SPDR S&P Pharmaceuticals ETF shares in Q1 2015, an estimated $343K.
Dorsey Wright & Associates first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 4 quarters.
Dorsey Wright & Associates's State Street SPDR S&P Pharmaceuticals ETF position peaked at $683K in Q2 2014.
79 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2015.

Based on Dorsey Wright & Associates's 13F filing for Q1 2015, filed 20 Apr 2015.